Accounts Receivable	12 Months Ended
	Dec. 31, 2020
Receivables [Abstract]
Accounts Receivable	Accounts Receivable    As of December 31, 2020, the Company had accounts receivable of $8.3 million which relates to royalty revenue from sales of NARCAN®. At December 31, 2020 the Company's accounts receivable were from EBS and BARDA.